C
CTMX
Cytomx Therapeutics Inc
3.280
-0.010-0.30%After Hours: 3.280 0.000 0.00%19:30 08/21 EDT
OPEN/PREV CLOSE3.310/3.290
TODAY RANGE3.270-3.415
VOL2.89M
MARKET CAP714.71M
52 WEEK RANGE1.885-8.21
AVG VOL (3M)3.99M
% TURNOVER1.33%
TURNOVER--
P/E (TTM)-7.1710
% RANGE4.41%
EPS(TTM)-0.4574
P/E(FORWARD)-8.1438
P/B2.366
BVPS1.386
DIVIDEND--
P/S7.32
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP676.09M
SHARES OUTSTANDING217.90M
NEXT EARNINGS11/04-11/09
FREE FLOAT206.13M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·5d ago
CytomX Therapeutics (CTMX) Gets a Buy from J.P. Morgan
Dow Jones·08/13 15:35
CytomX Therapeutics Price Target Cut to $11.00/Share From $12.00 by JP Morgan
Dow Jones·08/13 15:35
CytomX Therapeutics Is Maintained at Overweight by JP Morgan
Seeking Alpha·08/12 20:24
CytomX Therapeutics: Promising Varseta-M With Comfortable Runway
Dow Jones·08/10 14:22
CytomX Therapeutics Price Target Cut to $14.00/Share From $15.00 by Guggenheim
Dow Jones·08/10 14:22
CytomX Therapeutics Is Maintained at Buy by Guggenheim
Benzinga·08/10 14:13
Guggenheim Maintains Buy on CytomX Therapeutics, Lowers Price Target to $14
TipRanks·08/10 11:35
CytomX Therapeutics price target lowered to $14 from $15 at Guggenheim
Simply Wall St·08/08 01:44
CytomX Therapeutics (CTMX) Stock Faces Revenue Collapse As Pipeline Hopes Carry The Story
TipRanks·08/07 08:37
Barclays Sticks to Their Buy Rating for CytomX Therapeutics (CTMX)
Press release·08/07 01:42
CYTOMX THERAPEUTICS, INC. FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2026